1/135
A series of flashcards aimed at reviewing concepts related to adverse drug events, their classification, mechanisms of hypersensitivity reactions, mutagenicity, and teratogenicity.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
An adverse drug event (ADE) is defined as __.
An injury resulting from the use of a drug.
Adverse drug reactions (ADRs) can be categorized as or .
predictable (type A) and unpredictable (type B).
Hypersensitivity reactions can be grouped as type I (), type II (), type III (), and type IV ().
anaphylaxis, cytotoxic, Immune complex, Delay.
Functional groups in drugs capable of covalent bonding include __, __, __, __, and __.
β-lactams, epoxides, α,β-unsaturated carbonyl, aromatic amines, sulfhydryl.
Mutagens cause and changes in DNA.
irreversible and heritable.
A teratogen is any agent that causes __ during pregnancy.
congenital deformities.
Approximately __% of birth defects are caused by exposure to a teratogen.
5%.
The period of organogenesis is most critical during __ of pregnancy.
day 20 to the end of the first trimester.
Penicillin hypersensitivity is caused by __ bonding to proteins.
covalent.
Types of drug allergic reactions include __, __, __, and __.
IgE mediated, Cytotoxic, Immune complex, Delayed type hypersensitivity.
ADRs in the U.S. account for __% of all hospitalizations.
3 to 7%.
An example of an anticoagulant that can lead to ADEs is __.
bleeding.
can cause hypoglycemia as an adverse drug event.
Diabetes agents.
Drug-related overdoses can result from usage of drugs.
improper; Opioids.
Immediate hypersensitivity reactions are mediated by __.
IgE antibodies.
Covalent bonding to macromolecules can trigger immune-mediated drug hypersensitivity reactions due to the __ produced.
hapten.
ARBs, ACE inhibitors, and __ are associated with higher risks of ADRs.
calcium channel blockers.
In the context of ADEs, __ refers to the overuse or misuse of medications.
Medication errors.
Haptenation is predominantly important for which type of hypersensitivity reaction? __.
Type IV.
The term __ refers to drugs that can interfere with normal fetal development.
teratogens.
Mutagenic agents include __, __, and __.
epoxides, alkylating agents, analogs to DNA bases.
Covalent bonding to __ is one of the mechanisms leading to drug hypersensitivity.
sulfhydryl groups.
The __ isomers of thalidomide has been found to be teratogenic.
S'.
ADRs can occur during __% of hospitalizations.
10 to 20%.
The principal health issues connected with the use of __ involves polysystemic reactions.
opioids.
The overall __ of adverse drug reactions tends to increase in advanced age and with polypharmacy.
incidence.
Drug allergies can manifest as __, __, and __ reactions.
urticaria, bronchospasm, anaphylaxis.
Clinical manifestations of drug hypersensitivity include __, __, fever, and malaise.
cutaneous symptoms, respiratory issues.
The __ effect refers to the generation of adverse drug reactions due to genetic factors.
idiosyncratic.
In adults, exposure to teratogens can lead to __ defects in newborns.
congenital.
Drug molecules often activate immune responses by forming __ with proteins.
covalent bonds.
Small reactive molecules involved in immune reactions are often referred to as __.
haptens.
An important factor in the classification of adverse events is the __ of the drug involved.
dosage.
Polypharmacy increases the risk of __ and possible adverse reactions.
drug interactions.
The main therapeutic application of thalidomide today is in treating complications of __.
leprosy.
Most drugs have the potential to cause __, regardless of their therapeutic effects.
adverse drug reactions.
Antibodies involved in hypersensitivity reactions are primarily __.
IgE.
The __ Action Plan aims to address common and preventable ADEs.
ADE.
High-risk populations for ADEs often include patients on __, __, and __.
anticoagulants, diabetes agents, opioids.
Examples of __ adverse reactions include allergic reactions and other hypersensitivity events.
predictable.
Drug Hypersensitivity Reactions that are immediate are predominantly mediated by __ cells.
mast.
True or false: All drugs have the potential for causing ADRs regardless of their intended effects. __
True.
Anaphylactic reactions are classified as __ hypersensitivity reactions.
Type I.
Antigen presenting cells play a vital role in the __ of hypersensitivity reactions.
activation.
Severe ADRs may be expressed overnight leading to __.
serious morbidity.
Examples of antigens that can mediate drug allergies include __.
proteins.
Drugs that covalently bond with proteins can sometimes lead to generation of a __ response.
humoral.
A higher incidence of ADRs has been noted with __ and certain drug classes like those involved in chronic management conditions.
polypharmacy.
The __ reaction is often observed in beta-lactam antibiotic hypersensitivity.
cytotoxic.
The risk of ADRs increases with the __ of medication administration.
duration.
Medication safety practices aim to minimize things like and errors.
prescribing; monitoring.
Different therapeutic classes of drugs yield different __ for reactions based on usage.
risk factors.
Examples of __ adverse drug reactions include those that activate the immune response.
unpredictable.
Penicillin is associated with a higher incidence of __ compared to non-beta-lactams.
drug allergies.
Therapeutic management of patients involves monitoring for __ after medication administration.
adverse reactions.
The involvement of __ in allergic reactions can exacerbate the response to drug exposure.
genetic predisposition.
Covalent modifications of proteins that lead to hypersensitivity reactions are often referred to as __.
haptenation.
The timing of hypersensitivity reactions can vary, with immediate reactions typically manifesting within __ after exposure.
minutes.
Progressive symptoms of hypersensitivity can lead to __, making recognition essential.
anaphylaxis.
A drug that influences the immune system or alters immune responses is termed an __ modifier.
immunological.
Drugs that interact with cell-surface receptors can potentially lead to a __ response.
cell-mediated.
The analysis of __ for ADR susceptibility is becoming increasingly relevant in clinical practices.
pharmacogenomics.
Adverse drug reactions can complicate the clinical management of patients with __ or multiple conditions due to complexity.
comorbidities.
Histamine release is a critical step in the response to __ reactions.
Type I hypersensitivity.
Reactions to certain drugs might be enhanced by previously existing __ to them due to prior exposures.
sensitization.
The __ of adverse drug events can lead to significant healthcare costs.
prevalence.
A major consideration in understanding teratogenicity is the timing and __ of exposure during pregnancy.
duration.
True or false: Mutagens cause irreversible changes to DNA which can affect future generations. __
True.
Teratogenic agents create potential __ for developing abnormalities in embryos.
risk factors.
The presence of drug-specific antibodies indicates prior __ to that specific medication.
exposure.
Incidence of drug-induced hypersensitivity often correlates to __ factors such as dosage and genetic disposition.
external.
Research in drug discovery often focuses on elucidating the mechanisms of __ related to hypersensitivity.
toxicity.
Post-marketing surveillance is essential for detecting previously unknown __ drugs.
safe.
Pharmacovigilance encompasses all activities related to the detection, assessment, understanding, and prevention of __.
adverse effects.
Chronic exposure to teratogens can lead to long-lasting __ in affected individuals.
health impacts.
Adequate monitoring and risk assessment are crucial for __ populations and concurrent medication utilizations.
at-risk.
Drug patch tests can assist in assessing __ to specific medications in patients.
allergies.
Type II hypersensitivity is also known as __ hypersensitivity.
cytotoxic.
Prescribing errors can occur at any point in the __ process including post-marketing.
prescribing.
Therapeutic decision-making must take into account a patient’s potential for __.
allergic reactions.
Contention around drug safety is high regarding __ reactions and their potential for harm.
adverse.
The establishment of reverse transcriptase in HIV therapeutics demonstrates a fine balance between efficacy and __.
toxicity.
Genetic testing can inform clinicians about potential __ or expressions affecting drug metabolism.
polymorphisms.
Olanzapine is one of several medications implicated in __ reactions leading to ADRs in psychiatric settings.
adverse.
Substantial literature exists concerning the __ for hereditary predispositions to ADRs.
in-depth analysis.
Antigenic cross-reactivity in drug allergies can lead to subsequent __ in treatment effectiveness.
loss.
Recombinant technology can help in synthesizing __ that mimic human proteins to minimize reactions.
medications.
Figures from different studies show that certain age groups experience higher rates of __ after medication exposure.
reactions.
Multidisciplinary approaches are necessary to properly address __ associated with drug therapies.
responses.
Pharmacovigilance systems are meant to proactively diminish adverse __ outcomes in medications.
therapeutic.
Public health campaigns highlight awareness of drug-induced __ to improve patient safety.
allergies.
Biologics often show a unique profile concerning the incidence of __ among treated populations.
reactions.
Histological techniques study drug-induced __, providing insights into their potential causes.
changes.
Responsive measures regarding drug allergies include clear labeling and __ mechanisms for patient education.
communication.
Histamine release due to drug exposure can lead to __ and hypotension as potential outcomes.
anaphylaxis.
Research in drug safety increasingly involves studying the __ profiles of medications to determine risk.
adverse effect.
Current pharmacological strategies stress the importance of allergy history assessment prior to new drug __.
administration.
Patient education on potential drug side effects can enhance __ and adherence to treatment regimens.
safety.
Drug companies are often required to submit post-market studies to evaluate __ related to medications.
safety issues.
In-depth research on drug interactions can better inform clinicians about the potential for __ with certain agents.
reactions.